Product Code: MDS001B
Highlights:
The global electroceuticals market should reach $25.5 billion by the end of year 2022 and should reach more than $35.5 billion by year 2027, with a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2022-2027.
The cardioverter defibrillators and cardiac pacemaker product of the global electroceuticals market should reach $12.9 billion by the end of year 2022 and should reach more than $17.7 billion by year 2027 with a CAGR of 6.4% during the forecast period of 2022-2027.
The deep brain stimulation product of the global electroceuticals market should reach $1.2 billion by the end of year 2022 and should reach more than $2.2 billion by year 2027 with a CAGR of 11.5% during the forecast period of 2022-2027.
Report Scope:
This report highlights the current and future market potential for electroceuticals. It provides a detailed analysis of the competitive environment, regulatory scenario, and the drivers, restraints, opportunities, and trends in the market. The report also offers market projections through 2027.
This report covers the overall electroceuticals market, including cardiac pacemakers, implantable cardiac defibrillators, hearing aids and implants, and neurostimulation devices. The report also analyzes various end users of electroceuticals.
For this report, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa). Major countries, including the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are analyzed. Market data was provided for 2020, which served as the base year, and forecasts are estimated through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 19 data tables and 24 additional tables
- An overview of global markets and technologies for electroceuticals
- Analyses of global market trends, with data from 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Discussion on how electroceuticals are used as an alternative to drug-based remedies and analyses of endogenous and exogenous factors that are impacting the global market growth
- Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
- Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
- Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, and forecast
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players Abbott Laboratories, Boston Scientific, GlaxoSmithKline plc, Medtronic plc, Edwards Lifesciences Corp.
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing this Study
- What's New in this Update?
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
Chapter 2 Executive Summary
Chapter 3 Overview
- Introduction
- Neurostimulation
- Cardioverter Defibrillators and Cardiac Pacemakers
- Public Access Defibrillators
- Battery Technology for Implantable Cardiac Defibrillators
- Regulatory Framework
- United States
- European Union
- Japan
Chapter 4 Market Dynamics
- Market Drivers
- Increasing Incidence of CVD, Neurology and ENT Disorders
- Aging Population
- Increasing Healthcare Expenditures
- Focus on Non-drug Therapies and Reducing Opioid Usage
- Technology Innovations and New Product Developments
- Market Restraints and Challenges
- High Cost of Neurostimulation Procedures/Devices and Lack of Trained Healthcare Professionals
- Inconsistent Reimbursement Policies
Chapter 5 Impact of COVID-19 Pandemic
- Introduction
- Impact on Neurostimulation Market
- Impact on Market for ENT Devices
Chapter 6 Global Market for Electroceuticals by Product
- Cardioverter Defibrillators and Cardiac Pacemakers
- Neurostimulation
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Sacral Nerve Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Other Stimulators
- Hearing Aids and Implants
- Hearing Aid Devices
- Behind the Ear
- Completely in the Canal
- In the Ear
- Hearing Implants
- Cochlear Implants
- Bone Anchored Hearing Implants
- Middle Ear Implants
Chapter 7 Global Market for Electroceuticals by End User
- Hospitals and Clinics
- Homecare and Others
Chapter 8 Global Market for Electroceuticals by Region
- North America
- U.S.
- Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of the World
Chapter 9 Patent Review
- Introduction
- Patents on Hearing Aids and Implants
- Neurostimulation
- Cardiac
Chapter 10 Competitive Landscape
- Leading Companies in the Market for Neurostimulation Products
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Market for Hearing Aids and Implants by Company
- Key Developments
Chapter 11 Company Profiles
- ABBOTT LABORATORIES
- AXONICS MODULATION TECHNOLOGIES INC.
- BIOVENTUS LLC
- BIOTRONIK SE & CO. KG
- BOSTON SCIENTIFIC CORP.
- COCHLEAR AMERICAS
- COOK MEDICAL
- EDWARDS LIFESCIENCES CORP.
- GLAXOSMITHKLINE PLC
- LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
- LIVANOVA PLC
- MEDICO S.P.A.
- MEDTRONIC PLC
- MICROPORT SCIENTIFIC CORP.
- STRYKER CORP.
- ZOLL MEDICAL CORP.
Chapter 12 Appendix: Acronyms